UNSPSC 51453002: Amocarzine

This classification denotes an antihelminthic agent with the molecular formula C18H21N5O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 99807U412Y, chemically known as 1-piperazinecarbothioamide, 4-methyl-n-(4-((4-nitrophenyl)amino)phenyl)- but generally known as amocarzine, which bears US NIH Compound Identifier 5464102. European Medicines Agency schedules Amocarzine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05469MIG.

UNSPSC 51453002 Amocarzine is a Commodity code that does not reflect the actual scope of recent state and local procurement activity posted under it. The recent opportunities tagged to this code—including naloxone procurement, generic pharmaceuticals and OTC products, medical and first aid supplies for emergency response, and direct-to-manufacturer pharmacy initiatives—bear no relationship to amocarzine, a veterinary antiparasitic agent. State and local governments are not currently soliciting amocarzine through identifiable public procurement channels. The mismatch between the code's nominal scope and the work actually being bought suggests either a data-entry error in the opportunity tagging or that this code has been repurposed or misapplied in the source system.

The recent opportunities posted under this code involve issuing bodies across multiple jurisdictions and sectors: Seminole County, Florida (naloxone and drug deactivation systems); the Texas Health and Human Services Commission (direct-to-manufacturer prescription programs); the City of Tampa (medical and first aid supplies for fire rescue); and the Minnesota Multistate Cooperative Purchasing Alliance (generic pharmaceuticals and OTC products distributed across state and local facilities, including Oregon). Activity spans Florida, Texas, Minnesota, and Oregon. Because the code does not accurately capture what these issuing bodies are buying, the code itself offers limited value for business development targeting. Vendors interested in naloxone supply, emergency medical supplies, pharmaceutical wholesale distribution, or direct pharmacy contracting should monitor state health departments, county public health agencies, fire departments, and multistate cooperative purchasing consortia directly rather than relying on this code for opportunity discovery.